Whitepapers

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

Hyaluronic Acid: A wonder molecule for the cosmetic and pharma industries
Introduction Hyaluronic acid (HA) biopolymer is a naturally occurring material that helps retain moisture in the skin, eyes and lubricates the joints. However, with age,...
Read
Read
Bioanalytical Outsourcing Soars as Drugs Grow More Complex
Introduction The global pharma analytical testing outsourcing market is expected to reach $14.6 billion by 2030, expanding at a CAGR of 8.4%, as per ReportLinker....
Read
Read
Pharma supply chains: From fragile to agile
Introduction The pharmaceutical supply chain is undergoing a major transformation, shifting from fragile to agile models to enhance resilience. The COVID-19 pandemic exposed vulnerabilities in...
Read
Read
CMOs bask in pill promise
Introduction Contract manufacturing organizations (CMOs) are witnessing increased demand for outsourcing oral solid dosage (OSD), particularly from Europe. The global OSD contract manufacturing market, valued...
Read
Read
ADCs-Biological missiles for targeted therapies
Introduction The concept of targeted cytotoxic drug delivery to reduce systemic toxicity while increasing treatment efficacy was first introduced by Paul Ehrlich in 1913. However,...
Read
Read
Pharma 4.0-Taking CDMOs factory by storm
Introduction Contract manufacturing firms are ramping up the adoption of Pharma 4.0 technologies as regulators and customers increasingly look for transparency and integrity in manufacturing...
Read
Read
Net zero pledge: CDMOs go greener
Introduction According to industry reports, the pharmaceutical sector accounts for as much as 4.4% of emissions worldwide, and if no action is taken, its greenhouse...
Read
Read
New modalities hog the limelight
Introduction The biopharmaceutical industry is experiencing a paradigm shift as advanced therapies such as mRNA-based drugs, cell and gene therapies (CGTs), antibody-drug conjugates (ADCs), and...
Read
Read
Integrated outsourcing for drug development
Introduction This article explores the pros and cons of integrated versus standalone outsourcing services based on an industry-wide survey conducted by Pharma Intelligence in partnership...
Read
Read
pDNA-Cracking the Code
Introduction pDNA is critical to many advanced and emerging therapies, including cell and gene therapies and mRNA vaccines, as it is the key starting material...
Read
Read